[Pain therapy in pediatric oncology: pain experience, drugs and pharmacokinetics]

Insights

Effective pain management in pediatric cancer is crucial, especially for critically ill children. This includes appropriate analgesia, non-drug therapies, and careful monitoring to prevent trauma and ensure adequate pain relief.

Area of Science:

  • Pediatric oncology
  • Pain management
  • Palliative care

Context:

  • Pediatric cancer patients experience significant fear and pain from disease and procedures.
  • Pain assessment in young children is challenging due to subjectivity and developmental factors.
  • Effective pain management is a priority, particularly for vulnerable, critically ill children.

Purpose:

  • To review and present different analgesic treatment approaches for pediatric cancer pain.
  • To highlight the challenges and strategies for adequate pain therapy in palliative care for children.
  • To discuss the use of pharmacological and non-pharmacological interventions for pain in pediatric oncology.

Summary:

  • Pain management in pediatric cancer requires tailored approaches, including local anesthetics, strong opiates for severe pain, and patient-controlled analgesia for children aged six and above.
  • Non-drug therapies like physical affection and massage can complement pharmacological interventions.
  • Coanalgesics are recommended for neuropathic or phantom pain, with careful consideration of adverse effects.

Impact:

  • Optimizing pain management can prevent psychological trauma in pediatric cancer patients.
  • Provides guidance for pediatricians on selecting appropriate analgesia based on pain type and severity.
  • Emphasizes the importance of adequate pain control in improving the quality of life for children with cancer, especially in palliative settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...